Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06228235 · ClinicalTrials.gov registry record · NA
rTMS-concurrent Behavioral Priming for Reducing Smoking Cravings
A NA study of Smoking Behaviors and Smoking Reduction, sponsored by West Virginia University.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06228235: Recruiting NA study of Smoking Behaviors and Smoking Reduction, sponsored by West Virginia University.
NCT06228235 is a NA study of Smoking Behaviors and Smoking Reduction that is actively recruiting participants, run by West Virginia University. The registered enrollment target is 20 participants, below the 438-participant average among 21 other Smoking Behaviors trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06228235, a NA study of Smoking Behaviors and Smoking Reduction, is actively recruiting participants, sponsored by West Virginia University.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this pilot clinical trial is to test the effects of different types of thinking strategies at the time of repetitive Transcranial Magnetic Stimulation (rTMS), applied to the left Dorsolateral Prefrontal Cortex (DLPFC), on smoking craving and brain activity. Participants will be individuals with moderate to high smoking dependence (smoking at least 8 cigarettes a day) who have no intention of quitting in the next 3 months and are eligible to have rTMS and functional magnetic resonance imaging (fMRI). The main objectives of the trial are: 1. To compare the craving-reducing effects of "upregulation" and "downregulation" of craving while looking at pictures related to cigarette smoking during rTMS versus no regulation of craving while looking at neutral pictures unrelated to smoking. 'Upregulation" is thinking about the immediate positive experience of smoking. "Downregulation" is thinking about the long-term negative consequences of smoking. 2. To examine changes in brain activity that accompany craving reductions produced by rTMS paired with upregulation and downregulation of craving while looking at pictures related to cigarette smoking versus no regulation of craving while looking at neutral pictures unrelated to smoking. Following screening for eligibility, participants will be trained on how to do upregulation and downregulation of craving. The participants will then participate in 3 testing sessions. In each session, the participants will receive rTMS at 20Hz in 50 trains (2000 pulses total), followed immediately by fMRI. Sessions will take place 1-2 weeks apart and will differ in the type of thinking strategy participants will use while looking at pictures during the rTMS: * upregulation of craving while viewing smoking-related images * downregulation of craving while viewing smoking-related images * no regulation of craving while viewing neutral smoking-unrelated images The order of sessions will be randomized across participants.
Primary Outcome
Change in self-reported smoking cravings following high-frequency repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex paired with upregulation of craving during smoking cue exposure and downregulation of craving during smoking cue exposure relative to neutral cue exposure and no regulation of craving. Craving will be rated using the Tobacco Craving Questionnaire immediately following rTMS and on 1-4 Likert scale (1 = not at all; 4 = very much) in the course
Conditions Studied
Interventions
- DEVICE Repetitive transcranial magnetic stimulation (rTMS)
Study Locations (1)
West Virginia
- West Virginia University - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-04-16 |
| Est. Completion | 2026-05 |
| Phase | NA |
What NCT06228235 shows while recruiting
NCT06228235 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 438-participant average among 21 other Smoking Behaviors trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Smoking Behaviors appearing as the primary indexed condition, and to 1 intervention - of which Repetitive transcranial magnetic stimulation (rTMS) is the first listed.
NCT06228235 reports a single indexed study location in West Virginia.
Frequently Asked Questions
What is clinical trial NCT06228235 about?
NCT06228235 is a clinical study titled "rTMS-concurrent Behavioral Priming for Reducing Smoking Cravings". The objective of this pilot clinical trial is to test the effects of different types of thinking strategies at the time of repetitive Transcranial Magnetic Stimulation (rTMS), applied to the left Dorsolateral Prefrontal Cortex (DLPFC), on smoking craving and brain activity. Participants will be indi...
What is the current status of trial NCT06228235?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-04-16. Estimated completion is 2026-05.
What conditions does trial NCT06228235 study?
This clinical trial studies the following conditions: Smoking Behaviors, Smoking Reduction.
What interventions are being tested in trial NCT06228235?
The interventions under investigation include: Repetitive transcranial magnetic stimulation (rTMS) (DEVICE).
Who is sponsoring clinical trial NCT06228235?
This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06228235 being conducted?
This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Behaviors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06228235's enrollment target sits among peer trials
20 21st of 21 higher than 1 of 21 other Smoking Behaviors trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Behaviors trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families
RECRUITING · NA
-
Take A Break - Rural
RECRUITING · NA
-
Effects of E-cigs vs Pouches on Cigarette Smoking and Addiction
RECRUITING · NA
-
A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI